Ruan et al11 showed patients that died from COVID‐19 the cause of death was respiratory failure and cardiac injury in 33%, supported by Shi et al.13The presence of myocardial injury was associated with a significantly worse prognosis. A meta‐analysis by Li et al cardiac biomarkers were significantly higher in severe cases compared to milder cases (P < .001), this included troponin (P < .001), CK‐MB (P < .001) and NT‐proBNP (P = .009) but myoglobin was not (P = .052). Here, NPPB is linked to COVID-19.